High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
暂无分享,去创建一个
J. Tremblay | J. Huard | R. Roy | S. Verreault | M. Tremblay | J. Tremblay | Steeve Verreault | Raynald Roy | Johnny Huard | J. P. Tremblay | Martine Tremblay
[1] J. Huard,et al. Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection , 1994, Muscle & nerve.
[2] J. Huard,et al. Utilization of an Antibody Specific for Human Dystrophin to Follow Myoblast Transplantation in Nude Mice , 1993, Cell transplantation.
[3] C. Richards,et al. Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.
[4] E. Hoffman. Myoblast Transplantation: What's Going on? , 1993 .
[5] J. Bouchard,et al. Human myoblast transplantation: Preliminary results of 4 cases , 1992, Muscle & nerve.
[6] H. Blau,et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation , 1992, Nature.
[7] A. Irintchev,et al. Formation of new muscle fibres and tumours after injection of cultured myogenic cells , 1991, Journal of neurocytology.
[8] D. Bentley,et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. , 1991, American journal of human genetics.
[9] T. Partridge. Invited review: Myoblast transfer: A possible therapy for inherited myopathies? , 1991, Muscle & nerve.
[10] J. Huard,et al. Is dystrophin present in the nerve terminal nat the neuromuscular junction? An immunoshistochemical study of the heterozygote dystrophic (mdx) mouse , 1991, Synapse.
[11] H. Jockusch,et al. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.
[12] E. Hoffman,et al. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse , 1990, The Journal of cell biology.
[13] Simon C Watkins,et al. Somatic reversion/suppression of the mouse mdx phenotype in vivo , 1990, Journal of the Neurological Sciences.
[14] Y. Sunada,et al. Dense immunostainings on both neuromuscular and myotendon junctions with an anti-dystrophin monoclonal anfibody , 1989 .
[15] Y. Pouliot,et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. , 1989, The American journal of pathology.
[16] S. Dimauro,et al. Cell fractionation studies indicate that dystrophin is a protein of surface membranes of skeletal muscle. , 1989, The Biochemical journal.
[17] A. Engel,et al. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. , 1989, Human pathology.
[18] L. Kunkel,et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.
[19] D. Watt,et al. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells , 1988, Journal of the Neurological Sciences.
[20] S. Dimauro,et al. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.
[21] L. Kunkel,et al. Cell and fiber type distribution of dystrophin , 1988, Neuron.
[22] Hideo Sugita,et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.
[23] Simon C Watkins,et al. Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.
[24] R. Hodges,et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.
[25] L. Kunkel,et al. Subcellular fractionation of dystrophin to the triads of skeletal muscle , 1987, Nature.
[26] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[27] A. Monaco,et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.
[28] J. Harris,et al. FURTHER OBSERVATIONS ON THE PATHOLOGICAL RESPONSES OF RAT SKELETAL MUSCLE TO TOXINS ISOLATED FROM THE VENOM OF THE AUSTRALIAN TIGER SNAKE, NOTECHIS SCUTATUS SCUTATUS , 1978, Clinical and experimental pharmacology & physiology.
[29] P. Law,et al. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. , 1992, Cell transplantation.
[30] J. Morgan. Practical aspects of myoblast implantation: investigations on two inherited myopathies in animals. , 1990, Advances in experimental medicine and biology.
[31] K. Beam. Duchenne muscular dystrophy. Localizing the gene product. , 1988, Nature.
[32] T. Tsukahara,et al. Negative immunostaining of Duchenne muscular dystrophy(DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. , 1988 .
[33] S. Dimauro,et al. RAPID COMMUNICATION Immunocytochemical Study of Dystrophin in Muscle Culturesfrom Patients with Duchenne Muscular Dystrophy and Unaffected Control Patients , 2022 .
[34] P. Law,et al. Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. , 1988, Transplantation proceedings.
[35] M. W. Thompson,et al. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy , 1985, Nature.
[36] J. C. Vuletin,et al. A Light and Electron Microscopic Study , 1976 .